Innovative Health Sciences has successfully secured the exclusive Medical Device Regulations Quality Management System Certificate from BSI (CE MDR QMS), a leading notified body, thus facilitating ...

Barclays analyst Maurice Patrick maintained a Buy rating on IHS Holding (IHS – Research Report) today and set a price target of $6.00. The company’s shares closed yesterday at $3.76.

Innovative Health Sciences has successfully secured the exclusive Medical Device Regulations Quality Management System Certificate from BSI (CE MDR QMS), a leading notified body, thus facilitating the ...

For the first time in almost 20 years, Walmart has a new logo. The international retailer describes it as a “a comprehensive brand refresh,” but the online world hasn’t been quite so kind to ...

CHESTER, N.Y., Jan. 15, 2025 /PRNewswire/ -- Innovative Health Sciences (IHS) proudly announces a remarkable milestone in its journey to introduce the Insignis™ Infusion System into the global ...

Achieving MDR compliance at such an early stage highlights the dedication and expertise of the IHS team. This rigorous process required a meticulous adherence to MDR standards across all aspects ...

The Landesbank Hessen-Thüringen Girozentrale-Bond has a maturity date of 1/30/2031 and offers a coupon of 3.0000%. The payment of the coupon will take place 1.0 times per Year on the 30.01.. The ...